echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Production Process of Canertinib

    The Production Process of Canertinib

    • Last Update: 2023-04-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Canertinib is a targeted therapy drug used to treat certain types of cancer, specifically those that are characterized by the presence of abnormalities in the Anaplastic Lymphoma Kinase (ALK) gene.
    The production process of canertinib involves several steps, from the extraction of the active ingredient to the final product.


    1. Extraction of the Active Ingredient: Canertinib is extracted from a plant called the Madagascar periwinkle.
      This plant is known to contain a variety of alkaloids, which have been found to have medicinal properties.
    2. Purification of the Active Ingredient: Once the active ingredient is extracted, it needs to be purified.
      This is done by using various chemical and physical methods to remove any impurities that may be present.
    3. Synthesis of Canertinib: After the active ingredient has been purified, it is then synthesized into canertinib.
      This involves a series of chemical reactions that are carried out in a laboratory setting.
    4. Quality Control: Before canertinib can be used as a medication, it must go through a series of quality control tests.
      This includes testing for purity, potency, and stability.
    5. Final Product: Once canertinib passes all of the quality control tests, it is then formulated into the final product.
      This can include adding excipients, such as fillers and binders, to make the medication more stable and easier to administer.
    6. Packaging and Distribution: Once the final product has been produced, it is then packaged into individual doses or bottles, and distributed to pharmacies and hospitals.
    7. Monitoring of side effects: Canertinib like all medications have potential side effects, so it is important to monitor patients for any adverse reactions and to report any serious side effects to the relevant authorities.

    In conclusion, the production process of canertinib is a multi-step process that requires precision and care.
    From the extraction of the active ingredient to the final product, every step must be carried out with care and attention to detail.
    Only then can we ensure that the final product is safe and effective for use in treating cancer.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.